# Commission Regulation (EC) No 508/1999 of 4 March 1999 amending Annexes I to IV to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin, Division 1.2.6

Extent: E+W+S+N.I.

Quinolones
Pharmacologically active substance(s)
Marker residue
Animal species
MRLs
Target tissues
Other provisions
Decoquinate
Decoquinate
Bovine, ovine
500 μg/kg
Muscle
Provisional MRLs expire on 1 July 2000
500 μg/kg
Fat
500 μg/kg
Liver
500 μg/kg
Kidney
Enrofloxacin
Sum of enrofloxacin and ciprofloxacin
Ovine
100 μg/kg
Muscle
Provisional MRLs expire on 1 July 1999
100 μg/kg
Fat
300 μg/kg
Liver
200 μg/kg
Kidney
Flumequine
Flumequine
Bovine, ovine, porcine, chicken
50 μg/kg
Muscle
Provisional MRLs expire on 1 January 2000
50 μg/kg
Fat or skin and fat
100 μg/kg
Liver
300 μg/kg
Kidney
Salmonidae
150 μg/kg
Muscle and skin
Marbofloxacin
Marbofloxacin
Bovine
150 μg/kg
Muscle
Provisional MRLs expire on 1 July 2000
50 μg/kg
Fat
150 μg/kg
Liver
150 μg/kg
Kidney
75 μg/kg
Milk
Porcine
150 μg/kg
Muscle
50 μg/kg
Skin and fat
150 μg/kg
Liver
150 μg/kg
Kidney

---
Source: https://www.legislation.gov.uk/eur/1999/508/annex/III/division/1/division/1.2/division/1.2.6 (the official version)
Page: https://openlegislation.uk/eu-regulation-1999-508/annex-III/division-1/division-1.2/division-1.2.6
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.